Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.52 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Allylphenol SCHEMBL10878333 | 0.96 | GABRA1 (0.48) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL2295999 | 0.94 | GABRA1 (0.53) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL160157 | 0.94 | GABRA1 (0.57) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL29381085 | 0.94 | GABRA1 (0.57) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL5489147 | 0.94 | GABRA1 (0.57) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL31591833 | 0.94 | GABRA1 (0.57) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL7752180 | 0.91 | GABRA1 (0.55) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL290636 | 0.91 | GABRA1 (0.55) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL7270143 | 0.91 | GABRA1 (0.55) | GABRA1GABRB2HSPA5AKR1B1POLB | |
| 2-Allylphenol SCHEMBL10529950 | 0.91 | GABRA1 (0.55) | GABRA1GABRB2HSPA5AKR1B1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2499 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023234935-A1 | BONDED MICROPARTICULATES PREPARATION AND APPLICATIONS THEREOF | VENKOR CORPORATION (US) | 2023-12-07 | — | — | WO | claimed |
| WO-2023208882-A1 | PHARMACEUTICAL COMPOSITION OF NILOTINIB | RENATA PHARMACEUTICALS (IRELAND) LIMITED (IE) | 2023-11-02 | — | — | WO | claimed |
| US-20230240986-A1 | INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS | ORPHAI THERAPEUTICS INC. | 2023-08-03 | — | — | US | claimed |
| US-11648199-B2 | Inhalable rapamycin formulation for treating age-related conditions | Al Therapeutics, Inc. (US) | 2023-05-16 | — | — | US | claimed |
| US-20220202768-A1 | DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM | CHEERS HEALTH, INC. (US) | 2022-06-30 | — | — | US | claimed |
| US-20210212942-A1 | INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS | ACADIA WOODS PARTNERS, LLC | 2021-07-15 | — | — | US | claimed |
| US-20200215027-A1 | DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM | THE TRUSTEES OF PRINCETON UNIVERSITY | 2020-07-09 | — | — | US | claimed |
| US-20170246303-A1 | NANOEMULSIONS | COMMW SCIENT IND RES ORG (AU) | 2017-08-31 | — | — | US | claimed |
| US-9675700-B2 | Topical tetracycline compositions | FOAMIX PHARMACEUTICALS LTD. (IL) | 2017-06-13 | — | — | US | claimed |
| US-9649275-B2 | Nanoemulsions | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-05-16 | — | — | US | claimed |
| EP-1675548-A2 | RIFALAZIL FORMULATIONS | Activbiotics, Inc. (US) | 2006-07-05 | — | — | EP | claimed |
| EP-1587517-A1 | ANTI-PROTOZOAL COMPOSITIONS COMPRISING DICLAZURIL | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-10-26 | — | — | EP | claimed |
| WO-2005079143-A2 | TOPICAL FORMULATIONS FOR THE TREATMENT OF SKIN CONDITIONS | OCCELL INC. (CA) | 2005-09-01 | — | — | WO | claimed |
| WO-2005063209-A1 | SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS OF A HIV PROTEASE INHIBITOR | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2005-07-14 | — | — | WO | claimed |
| US-20050123602-A1 | Rifalazil formulations | ACTIVBIOTICS PHARMA LLC | 2005-06-09 | — | — | US | claimed |
| WO-2005030142-A2 | RIFALAZIL FORMULATIONS | ACTIVBIOTICS, INC. (US) | 2005-04-07 | — | — | WO | claimed |
| WO-2004062673-A1 | ANTI-PROTOZOAL COMPOSITIONS COMPRISING DICLAZURIL | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-07-29 | — | — | WO | claimed |
| US-20040034021-A1 | Intravenous rifalazil formulation and methods of use thereof | ACTIVBIOTICS, INC. | 2004-02-19 | — | — | US | claimed |
| WO-2003101445-A1 | INTRAVENOUS RIFALAZIL FORMULATION AND METHODS OF USE THEREOF | ACTIVBIOTICS, INC. (US) | 2003-12-11 | — | — | WO | claimed |
| WO-1997034478-A1 | INSECTICIDAL COMPOSITION AND METHOD FOR PREPARING SAME | VIRBAC (FR) | 1997-09-25 | — | — | WO | claimed |